ASME’s VisualizeMED: Modeling and Simulation in Medicine will take place on April 14-15, 2021. This two-day virtual event is enabling the transformation of modeling and simulation in medicine by bringing together industry experts of technology and masters of technique who are effectively implementing it with the goal to increase the application and adoption on a global scale.
In APL Bioengineering, researchers have developed materials that can interface with an injured spinal cord and provide a scaffolding to facilitate healing. To do this, scaffolding materials need to mimic the natural spinal cord tissue, so they can be readily populated by native cells in the spinal cord, essentially filling in gaps left by injury. The researchers show how the pores improve efficiency of gene therapies administered locally to the injured tissues, which can further promote tissue regeneration.
Being able to make blind people see again sounds like the stuff of miracles or even science fiction. And it has always been one of the biggest challenges for scientists.
The heart cannot regenerate new tissue, because cardiomyocytes, or heart muscle cells, do not divide after birth. However, researchers have now developed a shape memory polymer to grow cardiomyocytes. Raising the material’s temperature turned the polymer’s flat surface into nanowrinkles, which promoted cardiomyocyte alignment. The research is part of the growing field of mechanobiology, which investigates how physical forces between cells and changes in their mechanical properties contribute to development, cell differentiation, physiology, and disease.
Researchers have developed new 4D hydrogels — 3D materials that have the ability to change shape over time in response to stimuli — that can morph multiple times in a preprogrammed or on-demand manner in response to external trigger signals.
Gene editing technology will play a vital role in climate-proofing future crops to protect global food supplies, according to scientists at The University of Queensland.
HSE University researchers have become the first in the world to discover genetic predisposition to severe COVID-19. The results of the study were published in the journal Frontiers in Immunology.
Fool the novel coronavirus once and it can’t cause infection of cells, new research suggests. Scientists have developed protein fragments that bind to the Spike protein, effectively tricking the virus into “shaking hands” with a replica rather than the receptor that lets the virus into a cell.
NASA, in collaboration with other leading space agencies, aims to send its first human missions to Mars in the early 2030s, while companies like SpaceX may do so even earlier.
Researchers have produced a groundbreaking new reference genome for the Asian malaria vector mosquito Anopheles stephensi. The achievement will help scientists engineer advanced forms of defense against malaria transmission, including targeted CRISPR and gene drive-based strategies.
Jonathan Dordick, the Howard P. Isermann ’42 Professor of Chemical and Biological Engineering at Rensselaer Polytechnic Institute, has been elected to the National Academy of Engineering (NAE), for his “contributions to methods for rapidly screening drug efficacy and toxicity, and biocatalytic technologies for improving human health.”
Wearable devices can identify COVID-19 cases earlier than traditional diagnostic methods and can help track and improve management of the disease, according to a Mount Sinai study.
Using patient data, artificial intelligence can make a 90 percent accurate assessment of whether a person will die from COVID-19 or not, according to new research at the University of Copenhagen.
Researchers from Cornell and Northwestern University have devised a new method of using extracts derived from bioengineered bacteria to create vaccines that protect against life-threatening infections caused by pathogenic bacteria.
Some promising biosensors and medical devices work well within pristine laboratory environments but may stop working once exposed to real-world conditions. A thick layer of foulants will quickly cover biosensors, and there is no good way to revive them once they quit working. Essentially, a biosensor is only as good as its antifouling properties. In APL Materials, researchers review a variety of approaches developed to combat fouling.
Our genetic codes control not only which proteins our cells produce, but also - to a great extent - in what quantity.
Thunderbird School of Global Management announces the first of two prestigious Hoffmann Fellowships appointed in collaboration with the World Economic Forum for post-doctoral research and policy innovation at the intersection of society, science and technology.
ORNL story tips: Volcanic microbes, unbreakable bonds and flood mapping
Exemplary faculty and students from Cal State Fullerton, CSUN and Sacramento State were honored during the virtual university-wide symposium.
In research published today in Integrative Biology, a team of engineers from Rensselaer developed an in vitro — in the lab — lymphatic vessel model to study the growth of tumor emboli, collections of tumor cells within vessels that are often associated with increased metastasis and tumor recurrence.
A team of researchers co-led by Berkeley Lab and Columbia University has developed a new material called avalanching nanoparticles that, when used as a microscopic probe, offers a simpler approach to taking high-resolution, real-time snapshots of a cell’s inner workings at the nanoscale.
Researchers at Karolinska Institutet in Sweden have developed, in collaboration with researchers in Germany and the U.S., new small antibodies, also known as nanobodies, which prevent the SARS-CoV-2 coronavirus from entering human cells.
Researchers show that microbes are capable of an incredible feat that could help reclaim a valuable natural resource and soak up toxic pollutants.
Researchers at Carnegie Mellon University report findings on an advanced nanomaterial-based biosensing platform that detects, within seconds, antibodies specific to SARS-CoV-2, the virus responsible for the COVID-19 pandemic.
Carrageenans, biologically active polysaccharides isolated from red algae and widely used in the food industry as stabilizers, thickeners, or jelly agents have an express effect on the immune systems of mice, a study reports.
In 1986, cellular biochemist Kazumitsu Ueda, currently at Kyoto University's Institute for Integrated Cell-Material Sciences (iCeMS), discovered that a protein called ABCB1 could transport multiple chemotherapeutics out of some cancer cells, making them resistant to treatment.
Scientists have suspected mutations in a cellular cholesterol transport protein are associated with psychiatric disorders, but have found it difficult to prove this and to pinpoint how it happens.
How can cells adhere to surfaces and move on them?
New research shows the same proteins that enable human senses such as smell also allow certain fungi to sense something they can eat.
GenScript USA Inc., the world’s leading research reagent provider, announced today that Brazil's National Health Surveillance Agency (ANVISA) (Agência Nacional de Vigilância Sanitária) has authorized the use of the cPass™ SARS-CoV-2 Neutralization Antibody Detection Kit for detecting neutralizing antibodies. The cPass test is the first and only ANVISA authorized test for detecting neutralizing antibodies to SARS-CoV-2. Neutralizing antibodies specifically block the ability of a virus to infect a cell and are well-recognized to confer immunity.
Researchers from Berkeley Lab and Los Alamos National Laboratory have developed new methods for the large-scale production, purification, and use of the radioisotope cerium-134, which could serve as a PET imaging radiotracer for a highly targeted cancer treatment known as alpha-particle therapy.
Newly published study reports InvisiMask™, a self-administered single-dose nasal spray, protects against SARS-CoV-2 infection for up to 10 hours in mice
Leaders in stem cell science and regenerative medicine will combine two separate courses into one in June 2021.
The plasma volume status of a patient is one of the top priorities in evaluating and treating many different conditions including, shock, sepsis, congestive heart failure, acute or chronic kidney disease, chronic pulmonary disease, as well as general postoperative care.
As the COVID-19 pandemic continues to spread across the world, testing remains a key strategy for tracking and containing the virus.
The University of Delaware’s Eleftherios (Terry) Papoutsakis, Unidel Eugene Du Pont Chair of Chemical and Biomolecular Engineering, has been named a fellow of the National Academy of Inventors. It is the highest professional distinction accorded only to academic inventors.
The New York Academy of Sciences is hosting two programs on Space Exploration this week, with topics including legal agreements for “off planet” governance, bioengineering to make space travel safer for astronauts, and questions of bio-ethics related to interplanetary travel.
Microalgae are a promising source of energy to replace fossil fuels, as they have several advantages over conventional crops used for commercial biodiesel. Microalgae have a shorter lifecycle and they can be developed in environments unfit for agriculture. In the Journal of Renewable and Sustainable Energy, researchers developed a methodology to analyze different species to select the best microalgae for use as an energy source by taking into account biological, economic, and environmental aspects.
November is National Diabetes Month, a time when the nation comes together to shed light on one of the leading causes of death and disability among U.S. citizens. The University of Texas at El Paso (UTEP) is joining the fight against the disease through innovative research made possible through a recent $1.2M grant by the National Institutes of Health to advance understanding of a critical diabetic heart condition.
Soos Technology, a poultry biotechnology startup based in Israel, won the $1 million grand prize in the Grow-NY competition, a global challenge focused on strengthening food and agriculture innovation in upstate New York.
A research team, including scientists from UC San Diego, Argonne National Laboratory and Oak Ridge National Laboratory, wins the Gordon Bell Special Prize for High Performance Computing-Based COVID-19 Research, presented during the SC20 virtual conference.
Industrial biotechnology aims to use microbes, such as bacteria, as factories to convert molecules into desirable products using enzymes. Scientists have now developed a framework to rapidly select from hundreds of options to design, build, and optimize enzymes without the need for intact cells.
Laurencin will accept the honor during the 2020 Virtual MRS Spring/Fall Meeting, where at 4:00 pm (ET), Wednesday, December 2, he will present his award lecture, Regenerative Engineering: Materials and Convergence.
ore than 1.1 million Medicare patients could die over the next decade because they cannot afford to pay for their prescription medications, according to a new study released today by the West Health Policy Center, a nonprofit and nonpartisan policy research group and Xcenda, the research arm of the drug distributor AmerisourceBergen.
A new chemical compound that uses bio-orthogonal click chemistry to target tumor cells while sparing healthy cells has entered clinical trials.
The United States’ global leadership on science technology faces formidable competition from the People’s Republic of China; however the U.S. can take actions to maintain its competitive edge while enhancing innovation and protecting national security, according to a new report from the University of California San Diego.
Pearls have long been favored as objects of beauty. Now, Purdue University innovators are using the gem to provide potential new opportunities for spectral information processing that can be applied to spectroscopy in biomedical and military applications.
Researchers from Kumamoto University (Japan) have developed a system to quickly and easily measure the antioxidant capacity of food.
Plastomics Inc., an agricultural biotech start-up developing the next generation of trait delivery technology, has been awarded a competitive grant from the United Soybean Board (USB) to develop disease resistant soybeans.
Argonne scientists, working as part of a national consortium of structural genomics experts, have greatly increased our knowledge of the virus that causes COVID-19.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right